These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8471778

  • 1. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study.
    Blume KG, Kopecky KJ, Henslee-Downey JP, Forman SJ, Stiff PJ, LeMaistre CF, Appelbaum FR.
    Blood; 1993 Apr 15; 81(8):2187-93. PubMed ID: 8471778
    [Abstract] [Full Text] [Related]

  • 2. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Blume KG, Long GD, Negrin RS, Chao NJ, Kusnierz-Glaz C, Amylon MD.
    Bone Marrow Transplant; 1994 Apr 15; 14 Suppl 4():S9-10. PubMed ID: 7728133
    [Abstract] [Full Text] [Related]

  • 3. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec 15; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM).
    Devergie A, Blaise D, Attal M, Tigaud JD, Jouet JP, Vernant JP, Bordigoni P, Ifrah N, Dauriac C, Cahn JY.
    Blood; 1995 Apr 15; 85(8):2263-8. PubMed ID: 7718899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.
    Zhao X, Xu Z, Li Z, Zhou X, Hu Y, Wang H.
    Cancer Med; 2024 Jan 15; 13(1):e6897. PubMed ID: 38164654
    [Abstract] [Full Text] [Related]

  • 8. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
    Emminger W, Emminger-Schmidmeier W, Haas OA, Urban C, Ambros P, Peters C, Mann G, Fink FM, Ferstl G, Höcker P.
    Bone Marrow Transplant; 1992 May 15; 9(5):313-8. PubMed ID: 1617314
    [Abstract] [Full Text] [Related]

  • 9. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
    Nademanee A, Schmidt GM, Parker P, Dagis AC, Stein A, Snyder DS, O'Donnell M, Smith EP, Stepan DE, Molina A.
    Blood; 1995 Aug 01; 86(3):1228-34. PubMed ID: 7620176
    [Abstract] [Full Text] [Related]

  • 10. Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up.
    Aschan J, Carlens S, Hägglund H, Klaesson S, Mattsson J, Remberger M.
    Clin Transplant; 1999 Dec 01; 13(6):512-9. PubMed ID: 10617242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A, Rocha V, Labopin M, Unal A, Ben Othman T, Campos A, Volin L, Poire X, Aljurf M, Masszi T, Socie G, Sengelov H, Michallet M, Passweg J, Veelken H, Yakoub-Agha I, Shimoni A, Mohty M.
    J Clin Oncol; 2013 Oct 01; 31(28):3549-56. PubMed ID: 23980086
    [Abstract] [Full Text] [Related]

  • 15. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 01; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 16. Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation.
    Shah AJ, Lenarsky C, Kapoor N, Crooks GM, Kohn DB, Parkman R, Epport K, Wilson K, Weinberg K.
    J Pediatr Hematol Oncol; 2004 Feb 01; 26(2):91-7. PubMed ID: 14767194
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
    Dusenbery KE, Daniels KA, McClure JS, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Kersey JH, Woods WG.
    Int J Radiat Oncol Biol Phys; 1995 Jan 01; 31(1):119-28. PubMed ID: 7995742
    [Abstract] [Full Text] [Related]

  • 18. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
    Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W, McDonald GB, Mori M, Schoch G, Hansen JA.
    J Clin Oncol; 1993 Feb 01; 11(2):304-13. PubMed ID: 8426208
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans.
    Kim I, Park S, Kim BK, Chang HM, Bang SM, Byun JH, Kim DJ, Min WS, Kim HJ, Kim CC.
    Clin Transplant; 2001 Jun 01; 15(3):167-72. PubMed ID: 11389706
    [Abstract] [Full Text] [Related]

  • 20. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
    Dusenbery KE, Steinbuch M, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Litz C, Kersey JH, Woods WG.
    Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):335-43. PubMed ID: 8892457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.